Latest: FDA Approves New Biosimilar for Oncology Treatment

Form Health Selected for Novo Nordisk’s NovoCare® Platform to Expand Obesity Care

0 Mins
What You Should Know: – Form Health, a provider of science-based obesity and cardiometabolic care, has announced its selection as a healthcare provider option on Novo Nordisk’s NovoCare® platform. – The NovoCare® platform connects patients with trusted healthcare providers for chronic care treatment. Form Health’s inclusion will expand access to high-quality, evidence-based care delivered by ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago